Manganese-mediated acceleration of age-related hearing loss in mice.

Nobutaka Ohgami, Ichiro Yajima, Machiko Iida, Xiang Li, Reina Oshino, Mayuko Y Kumasaka, Masashi Kato
Author Information
  1. Nobutaka Ohgami: Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  2. Ichiro Yajima: Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  3. Machiko Iida: Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  4. Xiang Li: Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  5. Reina Oshino: Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  6. Mayuko Y Kumasaka: Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  7. Masashi Kato: Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Abstract

Despite the fact that manganese (Mn) is known to be a neurotoxic element relevant to age-related disorders, the risk of oral exposure to Mn for age-related hearing loss remains unclear. In this study, we orally exposed wild-type young adult mice to Mn (Mn-exposed WT-mice) at 1.65 and 16.50 mg/L for 4 weeks. Mn-exposed WT-mice showed acceleration of age-related hearing loss. Mn-exposed WT-mice had neurodegeneration of spiral ganglion neurons (SGNs) with increased number of lipofuscin granules. Mn-exposed WT-mice also had increased hypoxia-inducible factor-1 alpha (Hif-1α) protein with less hydroxylation at proline 564 and decreased c-Ret protein in SGNs. Mn-mediated acceleration of age-related hearing loss involving neurodegeneration of SGNs was rescued in RET-transgenic mice carrying constitutively activated RET. Thus, oral exposure to Mn accelerates age-related hearing loss in mice with Ret-mediated neurodegeneration of SGNs.

References

  1. Hear Res. 2004 Sep;195(1-2):35-40 [PMID: 15350277]
  2. Neurotoxicology. 2002 Oct;23(4-5):645-51 [PMID: 12428736]
  3. Arch Otolaryngol Head Neck Surg. 2011 Dec;137(12):1183-9 [PMID: 22183895]
  4. Environ Health Perspect. 2007 Jul;115(7):1107-12 [PMID: 17637930]
  5. Neurotoxicology. 2011 Oct;32(5):596-605 [PMID: 21762725]
  6. Environ Health Perspect. 2011 Jan;119(1):138-43 [PMID: 20855239]
  7. Toxicol Ind Health. 2011 Mar;27(2):143-7 [PMID: 20858647]
  8. Ann Occup Hyg. 2002 Jul;46(5):455-63 [PMID: 12176760]
  9. Arch Toxicol. 2014 May;88(5):1185-6 [PMID: 24614979]
  10. Neuroreport. 2004 Oct 25;15(15):2353-6 [PMID: 15640754]
  11. J Biol Chem. 2010 Jun 11;285(24):18565-74 [PMID: 20395301]
  12. Lancet. 2005 Sep 24-30;366(9491):1111-20 [PMID: 16182900]
  13. Toxicol In Vitro. 2010 Jun;24(4):1208-14 [PMID: 20152896]
  14. J Biol Chem. 2003 May 2;278(18):15911-6 [PMID: 12606543]
  15. Free Radic Biol Med. 2002 Sep 1;33(5):611-9 [PMID: 12208347]
  16. Can J Public Health. 1985 May-Jun;76(3):171-3 [PMID: 4016649]
  17. J Biol Chem. 2006 Jun 2;281(22):15215-26 [PMID: 16565084]
  18. Toxicol Appl Pharmacol. 2009 Mar 15;235(3):261-7 [PMID: 19263519]
  19. Toxicol Lett. 2013 Mar 13;217(3):177-83 [PMID: 23262390]
  20. Cancer Res. 2002 Apr 15;62(8):2414-22 [PMID: 11956105]
  21. Oncogene. 1999 Jan 21;18(3):837-42 [PMID: 9989837]
  22. Environ Pollut. 2006 Jan;139(1):95-106 [PMID: 16009476]
  23. Environ Pollut. 2015 Nov;206:456-60 [PMID: 26275730]
  24. J Biochem Mol Toxicol. 2008 Sep-Oct;22(5):305-10 [PMID: 18972394]
  25. Arch Toxicol. 2014 Jan;88(1):47-64 [PMID: 23832297]
  26. Environ Health Perspect. 2006 Jan;114(1):124-9 [PMID: 16393669]
  27. Neuroscience. 2008 Jul 31;155(1):7-16 [PMID: 18565681]
  28. Neurotoxicology. 2012 Oct;33(5):1356-61 [PMID: 22975422]
  29. Nat Rev Genet. 2008 Apr;9(4):277-90 [PMID: 18283275]
  30. Neurobiol Aging. 2012 Mar;33(3):626.e25-34 [PMID: 21612845]
  31. Neurotoxicology. 2011 Mar;32(2):233-41 [PMID: 21182863]
  32. Environ Int. 2008 Aug;34(6):756-64 [PMID: 18291528]
  33. Gene Ther. 2011 Jun;18(6):560-8 [PMID: 21228883]
  34. Biol Trace Elem Res. 2011 Dec;144(1-3):1039-49 [PMID: 21611807]
  35. J Neurosci. 2006 Mar 29;26(13):3541-50 [PMID: 16571762]
  36. Antioxid Redox Signal. 2012 Feb 1;16(3):263-74 [PMID: 21923553]
  37. Neurotoxicology. 2012 Oct;33(5):1276-83 [PMID: 22884792]
  38. Exp Gerontol. 2007 Apr;42(4):327-36 [PMID: 17141999]
  39. Nat Genet. 2003 Sep;35(1):21-3 [PMID: 12910270]
  40. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13051-6 [PMID: 20616061]
  41. J Neurosci. 2006 Feb 15;26(7):2115-23 [PMID: 16481444]
  42. J Expo Sci Environ Epidemiol. 2016 Sep;26(5):488-93 [PMID: 26464097]
  43. Arch Otolaryngol Head Neck Surg. 1999 Jun;125(6):654-9 [PMID: 10367922]

MeSH Term

Aging
Animals
Disease Models, Animal
Hearing Loss
Hydroxylation
Hypoxia-Inducible Factor 1, alpha Subunit
Manganese
Mice
Mice, Transgenic
Nerve Degeneration
Phosphorylation
Proline
Proto-Oncogene Proteins c-ret
Spiral Ganglion
Up-Regulation

Chemicals

Hif1a protein, mouse
Hypoxia-Inducible Factor 1, alpha Subunit
Manganese
Proline
Proto-Oncogene Proteins c-ret
Ret protein, mouse

Word Cloud

Created with Highcharts 10.0.0age-relatedhearinglossMnmiceMn-exposedWT-miceSGNsaccelerationneurodegenerationoralexposureincreasedproteinDespitefactmanganeseknownneurotoxicelementrelevantdisordersriskremainsunclearstudyorallyexposedwild-typeyoungadult1651650 mg/L4weeksshowedspiralganglionneuronsnumberlipofuscingranulesalsohypoxia-induciblefactor-1alphaHif-1αlesshydroxylationproline564decreasedc-RetMn-mediatedinvolvingrescuedRET-transgeniccarryingconstitutivelyactivatedRETThusacceleratesRet-mediatedManganese-mediated

Similar Articles

Cited By